Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113 100%), type I respiratory failure (18/35 51%), sepsis (113 100%), acute cardiac injury (72/94 77%), heart failure (41/83 49%), alkalosis (14/35 40%), hyperkalaemia (42 37%), acute kidney injury (28 25%), and hypoxic encephalopathy (23 20%). Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)).

Male sex was more predominant in deceased patients (83 73%) than in recovered patients (88 55%). The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). Data were collected until 28 February 2020.Д¬linical characteristics and laboratory findings were obtained from electronic medical records with data collection forms. To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died.ДЄmong a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed.

Irc 368